Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glial Tumor of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07831772
What this trial is testing

REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaNewly Diagnosed GlioblastomaBrain Tumor
University of Minnesota 4
Early research (Phase 1)Study completedNCT01158300
What this trial is testing

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 28
Early research (Phase 1)Ended earlyNCT01269411
What this trial is testing

RO4929097 in Treating Patients With Recurrent Invasive Gliomas

Who this might be right for
Adult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 22
Large-scale testing (Phase 3)Study completedNCT00154375
What this trial is testing

Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma

Who this might be right for
Glioblastoma MultiformeAstrocytoma
Novartis Pharmaceuticals 240
Testing effectiveness (Phase 2)Study completedNCT00093964
What this trial is testing

Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)

Who this might be right for
Glioblastoma Multiforme
EMD Serono 81
Very early researchLooking for participantsNCT04655404
What this trial is testing

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine Glioma
Nationwide Children's Hospital 15
Testing effectiveness (Phase 2)Ended earlyNCT01986348
What this trial is testing

Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas

Who this might be right for
GlioblastomaGlioma
Karyopharm Therapeutics Inc 76
Testing effectiveness (Phase 2)Study completedNCT00331526
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Hoag Memorial Hospital Presbyterian 83
Testing effectiveness (Phase 2)Study completedNCT00038493
What this trial is testing

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT05630209
What this trial is testing

Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)

Who this might be right for
Brain Tumor
InSightec 10
Testing effectiveness (Phase 2)Study completedNCT03665545
What this trial is testing

Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma

Who this might be right for
Glioblastoma MultiformeGlioblastoma, AdultGlioma of Brain+1 more
University Hospital, Geneva 18
Testing effectiveness (Phase 2)Study completedNCT00003466
What this trial is testing

Temozolomide in Treating Patients With Progressive Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 100
Testing effectiveness (Phase 2)Study completedNCT01817751
What this trial is testing

Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
GlioblastomaRecurrent Adult Brain NeoplasmMalignant Glioma+1 more
Virginia Commonwealth University 47
Not applicableLooking for participantsNCT05968053
What this trial is testing

Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)

Who this might be right for
Carotid Artery StenosisGliomaIntracranial Aneurysm+2 more
Beijing Tiantan Hospital 500
Not applicableStudy completedNCT01004523
What this trial is testing

Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 135
Very early researchLooking for participantsNCT07268053
What this trial is testing

A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases

Who this might be right for
Glioblastoma (GBM)Brain Metastasases
Nader Sanai 15
Testing effectiveness (Phase 2)Study completedNCT02285439
What this trial is testing

Study of MEK162 for Children With Low-Grade Gliomas

Who this might be right for
Low-Grade GliomasMalignant Neoplasms, BrainSoft Tissue Neoplasms
Children's Hospital Los Angeles 105
Testing effectiveness (Phase 2)Study completedNCT00870181
What this trial is testing

ADV-TK Improves Outcome of Recurrent High-Grade Glioma

Who this might be right for
Malignant Glioma of BrainGlioblastoma
Huazhong University of Science and Technology 47
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Not applicableActive Not RecruitingNCT04553757
What this trial is testing

Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma

Who this might be right for
Brain NeoplasmLow Grade GliomaSeizure Disorder
M.D. Anderson Cancer Center 100
Next Page